Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.
Königsbrügge O, Schmaldienst S, Auinger M, Klauser-Braun R, Lorenz M, Tabernig S, Kletzmayr J, Enzenberger B, Eigner M, Hecking M, Siller-Matula JM, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: kletzmayr j. Atherosclerosis. 2020 Apr;298:1-6. doi: 10.1016/j.atherosclerosis.2020.02.011. Epub 2020 Feb 16. Atherosclerosis. 2020. PMID: 32126388
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Haas M, Leko-Mohr Z, Roschger P, Kletzmayr J, Schwarz C, Mitterbauer C, Steininger R, Grampp S, Klaushofer K, Delling G, Oberbauer R. Haas M, et al. Among authors: kletzmayr j. Kidney Int. 2003 Mar;63(3):1130-6. doi: 10.1046/j.1523-1755.2003.00816.x. Kidney Int. 2003. PMID: 12631097 Free article. Clinical Trial.
Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).
Königsbrügge O, Lorenz M, Auinger M, Schmaldienst S, Klauser-Braun R, Kletzmayr J, Grilz E, Posch F, Antlanger M, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: kletzmayr j. Thromb Res. 2017 Oct;158:59-64. doi: 10.1016/j.thromres.2017.08.011. Epub 2017 Aug 19. Thromb Res. 2017. PMID: 28843824
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
Königsbrügge O, Posch F, Antlanger M, Kovarik J, Klauser-Braun R, Kletzmayr J, Schmaldienst S, Auinger M, Zuntner G, Lorenz M, Grilz E, Stampfel G, Steiner S, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: kletzmayr j. PLoS One. 2017 Jan 4;12(1):e0169400. doi: 10.1371/journal.pone.0169400. eCollection 2017. PLoS One. 2017. PMID: 28052124 Free PMC article.
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study.
Königsbrügge O, Meisel H, Beyer A, Schmaldienst S, Klauser-Braun R, Lorenz M, Auinger M, Kletzmayr J, Hecking M, Winkelmayer WC, Lang I, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: kletzmayr j. J Thromb Haemost. 2021 Dec;19(12):2984-2996. doi: 10.1111/jth.15508. Epub 2021 Sep 5. J Thromb Haemost. 2021. PMID: 34418291 Free article.
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.
Weseslindtner L, Neumann-Haefelin C, Viazov S, Haberstroh A, Kletzmayr J, Aberle JH, Timm J, Ross SR, Klauser-Braun R, Baumert TF, Roggendorf M, Thimme R, Holzmann H. Weseslindtner L, et al. Among authors: kletzmayr j. J Hepatol. 2009 Apr;50(4):693-704. doi: 10.1016/j.jhep.2008.11.023. Epub 2009 Jan 27. J Hepatol. 2009. PMID: 19231006
50 results